Form 8-K - Current report:
SEC Accession No. 0001437749-23-016750
Filing Date
2023-06-06
Accepted
2023-06-06 16:13:34
Documents
13
Period of Report
2023-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioli20230602_8k.htm   iXBRL 8-K 23062
  Complete submission text file 0001437749-23-016750.txt   155541

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA blfs-20230601.xsd EX-101.SCH 3600
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blfs-20230601_def.xml EX-101.DEF 11531
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blfs-20230601_lab.xml EX-101.LAB 15413
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blfs-20230601_pre.xml EX-101.PRE 11687
7 EXTRACTED XBRL INSTANCE DOCUMENT bioli20230602_8k_htm.xml XML 2580
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 23996220
SIC: 3845 Electromedical & Electrotherapeutic Apparatus